Neuropathologies can be classified, on the basis of post-mortem histopathology and by using machine learning, into six transdiagnostic clusters associated with clinical phenotypes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
12 February 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41551-020-00628-2
References
Soria Lopez, J. A., Gonzalez, H. M. & Leger, G. C. Handb. Clin. Neurol. 167, 231–255 (2019).
Butler, P. M. & Chiong, W. Handb. Clin. Neurol. 163, 391–410 (2019).
Kovacs, G. G. Handb. Clin. Neurol. 145, 355–368 (2017).
Alafuzoff, I. & Hartikainen, P. Handb. Clin. Neurol. 145, 339–353 (2017).
Peng, C., Trojanowski, J. Q. & Lee, V. M. Nat. Rev. Neurol. 16, 199–212 (2020).
Elahi, F. M. & Miller, B. L. Nat. Rev. Neurol. 13, 457–476 (2017).
Karanth, S. et al. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1741 (2020).
Cornblath, E. J. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0593-y (2020).
Toledo, J. B. et al. Alzheimers Dement. 10, 477–484 (2014).
Ransohoff, R. M. Science 353, 777–783 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.V. owns stocks and has received consultancy fees from Accure Therapeutics, Health Engineering, QMENTA, Attune Neurosciences, CLight, NeuroPrex and Spiral Therapeutics. These companies are not associated with this work. J.C.M. has received consultancy fees from Biogen and is on their Speaker Bureau, and has received research support from AbbVie, Biogen, Esai, Eli Lilly and Company, and Novartis. R.B.-Y. declares no competing interests.
Rights and permissions
About this article
Cite this article
Villoslada, P., Baeza-Yates, R. & Masdeu, J.C. Reclassifying neurodegenerative diseases. Nat Biomed Eng 4, 759–760 (2020). https://doi.org/10.1038/s41551-020-0600-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-020-0600-3